Colloidal Drug Delivery Systems in Vaccine Delivery

被引:19
作者
Beg, Sarwar [1 ]
Samad, Abdus [2 ]
Nazish, Iram [1 ]
Sultana, Ruksar [3 ]
Rahman, Mahfoozur [4 ]
Ahmad, Md Zaki [4 ]
Akbar, Md [5 ]
机构
[1] Hamdard Univ, Dept Pharmaceut, Fac Pharm, New Delhi, India
[2] Fortis Clin Res Ltd, Dept Pharmacokinet & Stat, Sunflag Hosp & Res Ctr, Faridabad 121002, Haryana, India
[3] Natl Inst Technol, Dept Biotechnol & Med Engn, Rourkela, Orissa, India
[4] Dreamz Coll Pharm, Dept Pharmaceut, Sundernagar, HP, India
[5] Hamdard Univ, Dept Pharmacol, Fac Pharm, New Delhi, India
关键词
Immune Adjuvants; Carbon nanotubes; Immunization; Nanocarriers; Vesicular carriers; HEPATITIS-B-VACCINE; BIODEGRADABLE POLYMER MICROSPHERES; INFLUENZA VACCINES; ANTIBODY-RESPONSES; CARBON NANOTUBES; MUCOSAL DELIVERY; ORAL DELIVERY; GENE DELIVERY; DNA VACCINE; IMMUNOSTIMULATING COMPLEXES;
D O I
10.2174/138945013804806523
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Vaccines play a vital role in the field of community medicine to combat against several diseases of human existence. Vaccines primarily trigger the acquired immune system to develop long-lasting immunity against pathogens. Conventional approaches for vaccine delivery lacks potential to target a particular antigen to develop acquired immunity by specific antibodies. Recent advancements in vaccine delivery showed that inclusion of adjuvants in vaccine formulations or delivery of them in a carrier helps in achieving desired targeting ability, reducing the immunogenicity and significant augmentation in the immune response. Colloidal carriers (liposomes, niosomes, microspheres, proteosomes, virosomes and virus like particles (VLPs), antigen cochleates, dendrimers and carbon nanotubes) have been widely explored for vaccine delivery. Further, surface engineering of these carriers with ligands, functional moieties and monoclonal antibodies tend to enhance the immune recognition potential of vaccines by differentiation of antigen specific memory T-cells. The current review, therefore, provides an updated account on the recent advancements in various colloidal delivery systems in vaccine delivery, outlining the mechanism of immune response initiated by them along with potential applications and marketed instances in an explicit manner.
引用
收藏
页码:123 / 137
页数:15
相关论文
共 153 条
[1]   Intranasal administration of proteoliposome-derived cochleates from Vibrio cholerae O1 induce mucosal and systemic immune responses in mice [J].
Acevedo, Reinaldo ;
Callico, Adriana ;
del Campo, Judith ;
Gonzalez, Elizabeth ;
Cedre, Barbara ;
Gonzalez, Lissette ;
Romeu, Belkis ;
Zayas, Caridad ;
Lastre, Miriam ;
Fernandez, Sonsire ;
Oliva, Reynaldo ;
Garcia, Luis ;
Luis Perez, Jose ;
Perez, Oliver .
METHODS, 2009, 49 (04) :309-315
[2]   Chitosan microparticles as oral delivery system for tetanus toxoid [J].
Ahire, Vijay J. ;
Sawant, Krutika K. ;
Doshi, Jignesh B. ;
Ravetkar, Satish D. .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2007, 33 (10) :1112-1124
[3]   LIPOSOMES AS IMMUNOLOGICAL ADJUVANTS [J].
ALLISON, AC ;
GREGORIADIS, G .
NATURE, 1974, 252 (5480) :252-252
[4]   BIODEGRADABLE MICROSPHERES AS CONTROLLED-RELEASE TETANUS TOXOID DELIVERY SYSTEMS [J].
ALONSO, MJ ;
GUPTA, RK ;
MIN, C ;
SIBER, GR ;
LANGER, R .
VACCINE, 1994, 12 (04) :299-306
[5]   Intranasal vaccination against plague, tetanus and diphtheria [J].
Alpar, HO ;
Eyles, JE ;
Williamson, ED ;
Somavarapu, S .
ADVANCED DRUG DELIVERY REVIEWS, 2001, 51 (1-3) :173-201
[6]   Lipid A and liposomes containing lipid A as antigens and adjuvants [J].
Alving, Carl R. ;
Rao, Mangala .
VACCINE, 2008, 26 (24) :3036-3045
[7]   LIPOSOMES AS CARRIERS OF ANTIGENS AND ADJUVANTS [J].
ALVING, CR .
JOURNAL OF IMMUNOLOGICAL METHODS, 1991, 140 (01) :1-13
[8]   ISCOMs (immunostimulating complexes): The first decade [J].
Barr, IG ;
Mitchell, GF .
IMMUNOLOGY AND CELL BIOLOGY, 1996, 74 (01) :8-25
[9]   Advancement in carbon nanotubes: basics, biomedical applications and toxicity [J].
Beg, Sarwar ;
Rizwan, Mohammad ;
Sheikh, Asif M. ;
Hasnain, M. Saquib ;
Anwer, Khalid ;
Kohli, Kanchan .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 2011, 63 (02) :141-163
[10]   Evaluations of unformulated and formulated dendrimer-based microbicide candidates in mouse and guinea pig models of genital herpes [J].
Bernstein, DI ;
Stanberry, LR ;
Sacks, S ;
Ayisi, NK ;
Gong, YH ;
Ireland, J ;
Mumper, RJ ;
Holan, G ;
Matthews, B ;
McCarthy, T ;
Bournel, N .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (12) :3784-3788